Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisis

Código QR

Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisis

Antoni Sicras-Mainar,1 Ruth Navarro-Artieda2 1Research Unit, Badalona Serveis Assistencials SA, 2Medical Documentation Unit, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain Objective: To describe antidepressant (AD) use in the treatment of major depressive disorder during a period of ec...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sicras-Mainar A, Navarro-Artieda R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	consumption antidepressants economic crisis Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/08fb03cf41ab447ab124c1c42452b6a0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune BT, et al.
Publicado: (2021)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha MK, et al.
Publicado: (2017)

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
por: Bhattacharjee S, et al.
Publicado: (2020)

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
por: Zeng D, et al.
Publicado: (2018)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
por: Park YM, et al.
Publicado: (2016)

Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
por: Larisa Duffy, et al.
Publicado: (2021)

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
por: Zhang L, et al.
Publicado: (2016)

Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
por: Blat Diana, et al.
Publicado: (2021)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada E, et al.
Publicado: (2016)

Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings
por: Antoni Sicras-Mainar, et al.
Publicado: (2008)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
por: Zuilhof Z, et al.
Publicado: (2018)

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
por: Weiller E, et al.
Publicado: (2017)

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
por: Durgam S, et al.
Publicado: (2016)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
por: Thase ME, et al.
Publicado: (2018)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi T, et al.
Publicado: (2017)

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
por: Otsubo T, et al.
Publicado: (2018)

Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
por: Sakai C, et al.
Publicado: (2021)

Association Between NR4A2 Gene Polymorphism and Depressive Symptoms and Antidepressant Effect
por: Song X, et al.
Publicado: (2021)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
por: Berman R, et al.
Publicado: (2011)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick D, et al.
Publicado: (2016)

Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment
por: G&eacute;rard A, et al.
Publicado: (2012)

Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study
por: Hsing SC, et al.
Publicado: (2020)

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China
por: Wang G, et al.
Publicado: (2019)

Immunoregulation and antidepressant effect of ketamine
por: Zhang Nan, et al.
Publicado: (2021)

Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex
por: Hu Q, et al.
Publicado: (2018)

Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study
por: Lin C, et al.
Publicado: (2018)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
por: Sugawara N, et al.
Publicado: (2020)

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia
por: Sicras-Mainar A, et al.
Publicado: (2014)

Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
por: Soraia Silva, et al.
Publicado: (2021)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
por: L. K. Khokhlov, et al.
Publicado: (2019)

Mind your state: Insights into antidepressant nonadherence
por: De Wet Wolmarans, et al.
Publicado: (2016)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study
por: Lunghi C, et al.
Publicado: (2020)

ACHIEVEMENT OF REMISSION AS A MODERN PURPOSE OF ANTIDEPRESSANT THERAPY
por: O. V. Petrunko
Publicado: (2014)

Attitudes and beliefs of patients with chronic depression toward antidepressants and depression
por: Jacob SA, et al.
Publicado: (2015)

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul P, et al.
Publicado: (2014)

Dissociative states in borderline personality disorder and their relationships to psychotropic medication
por: Pec O, et al.
Publicado: (2018)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
por: Michael Colla, et al.
Publicado: (2021)

The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
por: Liu X, et al.
Publicado: (2020)

Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review
por: Woranush W, et al.
Publicado: (2021)